<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2023cv00039/81214</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2023cv00039/81214/feed" rel="self" type="application/rss+xml" />
        <pubDate>Wed, 18 Nov 2026 12:50:50 -0800</pubDate>
        <lastBuildDate>Wed, 18 Nov 2026 12:50:50 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al - Docket Entries - Showing 1 through 11</description>
                                    <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Schladweiler, Benjamin) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098992</guid>
                <pubDate>
            Fri, 03 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H)(Schladweiler, Benjamin) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098991</guid>
                <pubDate>
            Fri, 03 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Kenneth S. Canfield, Dmitry V. Shelhoff, Edward D. Pergament, and Julia S. Kim for Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098990</guid>
                <pubDate>
            Thu, 02 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. Signed by Judge Gregory B. Williams on 2/1/23. (ntl) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098989</guid>
                <pubDate>
            Wed, 01 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: #1 Text of Proposed Order, #2 Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq., #3 Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq., #4 Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq., #5 Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.)(Schladweiler, Benjamin) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098988</guid>
                <pubDate>
            Tue, 31 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                SUMMONS Returned Executed by Merck Serono SA, Merck KGaA, Ares Trading SA.Aurobindo Pharma USA, Inc. served on 1/20/2023, answer due 2/10/2023. (Tigan, Jeremy) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098987</guid>
                <pubDate>
            Fri, 20 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                AFFIDAVIT of Service for Summons, Complaint and related papers served on Aurobindo Pharma Limited on January 19, 2023, filed by Ares Trading SA, Merck KGaA, Merck Serono SA. (Tigan, Jeremy) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098986</guid>
                <pubDate>
            Fri, 20 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20098985</guid>
                <pubDate>
            Wed, 18 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued as to Aurobindo Pharma Limited on 1/13/2023; Aurobindo Pharma USA, Inc. on 1/13/2023. (Attachments: #1 Summons Issued)(apk) (Attachment 1 replaced on 1/19/2023) (ntl). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19356026</guid>
                <pubDate>
            Fri, 13 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck KGaA for Ares Trading SA, Merck Serono SA filed by Ares Trading SA, Merck KGaA, Merck Serono SA. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19356025</guid>
                <pubDate>
            Fri, 13 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,713,947 B2 ;8,377,903 B2 ;10,849,919 B2. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19356024</guid>
                <pubDate>
            Fri, 13 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/5/2022. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 6/5/2025. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19356023</guid>
                <pubDate>
            Fri, 13 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19356022</guid>
                <pubDate>
            Fri, 13 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4043418.) - filed by Merck Serono SA, Merck KGaA, Ares Trading SA. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_19356021</guid>
                <pubDate>
            Fri, 13 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                </channel>
</rss>
